Malakoplakia in a patient with complicated urinary tract infection caused by extendedspectrum b-lactamase-producing Escherichia coli Dear Editor,
the typical finding of malakoplakia (Fig. 1B) . His fever persisted even after the 3-day cefazolin therapy. However, the urine culture revealed ESBL-producing E. coli with a multidrug resistant strain, but susceptible to carbapenems. Therefore, his cefazolin therapy was discontinued and 1-g iv drip of ertapenem was administered every day for a complete 7-day therapeutic course. A follow-up visit with cystoscopic examination revealed that his condition was resolved with urologic surgical intervention and the complete course of antibiotics therapy.
Malakoplakia is a uncommon tumor-like xanthogranulomatous disease that occurs commonly in the urinary tract, followed by the gastrointestinal tract. 2e4 The clinical manifestation of urinary tract malakoplakia is diverse, from asymptomatic to chronic cystitis, pyelonephritis, renal mass-like lesion, and complicated with obstructive uropathy. 2e4 Endoscopically, malakoplakia commonly presents with soft yellow to gray polyp-like lesions. 2 Histopathologically, it is characterized by distinctive MichaelisGutmann bodies and with positive von Kossa staining. 3 The etiology and pathogenesis of malakoplakia is still not fully understood, but multiple possible mechanisms have suggested that it may be related to chronic infection. The common organisms included E. coli, Proteus, Mycobacterium tuberculosis, and Staphylococcus aureus.
2e4 The macrophages or histiocytes incompletely digest microorganisms accumulated in lysosomes, leading to the mineralization of calcium and iron salts deposited in the cytoplasm and emulating biofilm formation, which is difficult to treat. 5 The MichaeliseGutmann bodies of malakoplakia can be highlighted by the Periodic acideSchiff (PAS) for iron and von Kossa stain for calcium, and this is the diagnostic characteristic (Fig. 1B) .
The treatment of malakoplakia involves antibiotics therapy and/or surgical resection. 2e4 If it is a susceptible pathogen, the antibiotics trimethoprim/sulphamethoxazole, rifampicin, and ciprofloxacin are the drugs of choice for biofilm-related organisms 5 because these drugs have good penetration into macrophages and contribute to intracellular bacteria death. For a multidrug-resistant microorganism such as ESBL-producing E. coli, carbapenems antibiotics plus surgical resection may be an alternative therapy.
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